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Abstract
Purpose: This study aimed to present guidance on the correlation between treatment nozzle and proton source parameters, and dose distribution of a passive double scattering compact proton therapy unit, known as Mevion S250.
Methods: All 24 beam options were modeled using the MCNPX MC code. The cal-
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culated physical dose for pristine peak, proﬁles, and spread out Bragg peak (SOBP)
were benchmarked with the measured data. Track‐averaged LET (LETt) and dose‐averaged LET (LETd) distributions were also calculated. For the sensitivity investigations, proton beam line parameters including Average Energy (AE), Energy Spread
(ES), Spot Size (SS), Beam Angle (BA), Beam Offset (OA), and Second scatter Offset
(SO) from central Axis, and also First Scatter (FS) thickness were simulated in different stages to obtain the uncertainty of the derived results on the physical dose and
LET distribution in a water phantom.
Results: For the physical dose distribution, the MCNPX MC model matched measurements data for all the options to within 2 mm and 2% criterion. The Mevion S250 was
found to have a LETt between 0.46 and 8.76 keV.μm–1 and a corresponding LETd
between 0.84 and 15.91 keV.μm–1. For all the options, the AE and ES had the greatest
effect on the resulting depth of pristine peak and peak‐to‐plateau ratio respectively.
BA, OA, and SO signiﬁcantly decreased the ﬂatness and symmetry of the proﬁles. The
LETs were found to be sensitive to the AE, ES, and SS, especially in the peak region.
Conclusions: This study revealed the importance of considering detailed beam
parameters, and identifying those that resulted in large effects on the physical dose
distribution and LETs for a compact proton therapy machine.
KEY WORDS
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1 | INTRODUCTION

added to the gantry due to the lack of an energy selection system in a
relatively short beamline. These absorbers signiﬁcantly complicate the

Proton therapy using compact passively scattered systems is undergo-

modeling of the system and justify careful characterization with precise

ing a technological evolution as it eliminates the requirement for a

and accurate methods to identify beam parameters, i.e. proton source

complex beam transport system.1 However, additional absorbers are

that affect the uncertainty of calculated proton dose distributions.2
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provided the original work is properly cited.
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On the other hand, beside the proton physical dose distribution, its
relative biological effectiveness (RBE) should also be taken into
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machine installed and commissioned in the S. Lee Kling Proton Therapy
Center at Barnes‐Jewish Hospital in St. Louis, MO, USA.

account.3–5 However, according to recent publications,3,6 there is a sig-

To the best of our knowledge, this is the ﬁrst reported simulation

niﬁcant variability in the RBE of protons as a function of depth or parti-

and sensitivity analysis of the Mevion S250 using MCNPX. The

cle energy in the beam. In radiation dosimetry, linear energy transfer

Mevion S250 machine is particularly noteworthy because of its

(LET) is one of the fundamental variables employed to derive the RBE.7

unique beam characterization, which is due to the lack of energy

According to the recently published AAPM TG‐256, voxel‐by‐voxel

selection and beam transportation systems, and mounting interest in

dose‐averaged LET can be employed as a valuable tool for biologically

single‐room proton unit.17

optimized treatment planning even without knowing dose‐ and tissue
endpoint‐speciﬁc RBE values accurately.4 Therefore, it is important to
provide accurate proton LET distributions with rigorous sensitivity analysis, in addition to the physical dose, for clinical applications.
Monte Carlo (MC) simulation, as a gold standard tool in simulating complex radiation transport,8 plays an increasingly important role

2 | MATERIALS AND METHODS
2.A | MCNPX MC simulation of Mevion S250
2.A.1 | Physical dose

in proton therapy.9–11 Moreover, MC calculated LET values can be

The Mevion S250 has 24 different beam options divided into large,

efﬁciently employed in the optimization of proton treatment plan-

deep, and small groups.2 Each beam conﬁguration is generated using

12

Considering these

a unique arrangement and combination of different beam line compo-

advantages, MC simulation “can be an alternative or complimentary

nents (Fig. 1). In order to acquire physical dose distribution data for

source of dosimetric data for developing, conﬁguring, and validating

each conﬁguration, three sets of measurements are taken: (a) pristine

analytical dose algorithms in clinical TPS”.1

peak, (b) lateral proﬁles in air, and (c) spread out Bragg peak (SOBP).

ning systems (TPS) for clinical applications.

In order to derive physical dose and LET distributions of a proton

To obtain pristine peaks and SOBPs, a parallel‐plate chamber

therapy unit by MC simulations, all major mechanical components of

(PPC05, IBA Dosimetry) was used to measure percent depth‐dose

the treatment nozzle should be modeled in detail.9,13,14 However, even

curves in a 3D scanning tank (Blue phantom, IBA Dosimetry America,

detailed simulation of all machine components cannot account for devi-

Bartlett, TN, USA) at nominal source‐to‐surface distance (SSD) of

ations, especially for the radiation source, from factory speciﬁca-

200 cm with radiation isocenter placed on the water surface. Lateral

tions.11,15,16 Furthermore, the source information provided by the

proﬁles in air were measured using a diode Edge detector (Sun Nuclear

manufacturer is often limited to spot size and nominal energy, and cus-

Corporation, Melbourne, FL, USA). The general guideline for acquiring

tomization of the MC model is required to match its results with the

beam data for photon machines has been described in the report of

measured data.

AAPM Task Group 106.18

The large number of adjustable parameters in a clinical proton

For the MC simulations, MCNPX was used in this work.19 Com-

therapy system (e.g., average energy, energy spread, spot size, beam

putations were performed using the facilities at the Washington

offset from central axis, etc.) demands a thorough sensitivity analysis

University, Center for High Performance Computing. The simulation

that provides important characteristics that are difﬁcult or impossible

was started by using the manufacturer’s speciﬁcations for all dimen-

to measure. In addition, the routine quality assurance processes can

sions and materials of each beam component. Then, average energy,

be signiﬁcantly facilitated by correlating the adjustable simulation

energy spread (FWHM), spot size, and First Scatter (FS) thickness

parameters with measured dose distributions.

were tuned to match the measured data (experimental results).

In this study, physical dose and LET distributions of a passive

For SOBP simulations, a user deﬁned beam current modulation

double scattering compact proton therapy unit, known as Mevion

(BCM) sequence was deﬁned considering the rotation angle of the

S250 (Mevion Medical Systems, Littleton, MA, USA), were calculated

range modulator wheel.10,20 According to the method described by

using the Monte Carlo N‐Particle eXtended (MCNPX) MC code. The

Polf et al. individual pristine Bragg peaks were created and weighted

physical dose results were benchmarked with measured commission-

to form a uniform and ﬂat SOBP with the desired modulation.10

ing data. Additionally, a sensitivity analysis of the Mevion S250 unit

For the pristine peak and lateral proﬁles, for each dose point,

was done by adding small variations of treatment nozzle and proton

MCNPX derived data were compared with the measurements by cal-

source parameters and characterizing their impact on the depth of

culating the local difference. In addition, for the penumbra region of

the pristine peak, shape, and symmetry of the resulting dose proﬁles,

the proﬁles, distance between the 80% and 20% dose levels was

and LET distribution in a water phantom.

compared. SOBP was evaluated by comparing the simulated results

The aim of this work is to present guidance on the correlation

and measured data, on the SOBP width as deﬁned by the proximal

between treatment nozzle and proton source parameters, and physical

95% to the distal 90% dose, beam range, and the depth of distal

dose distribution to the following: for researchers modeling clinical pro-

20% dose. The beam range was deﬁned as the depth of 90% dose

ton beam systems, and clinical medical physicists tasked with physically

(D90%) on distal fall‐off.

tuning their passive double scattering compact proton therapy unit to

The simulations in water and air were performed with 2.0 × 109

bring beam parameters to within clinically acceptable levels. Moreover,

and 7.5 × 108 histories respectively. Generally, for the so‐called “good

this work proposes to create a reference library to troubleshoot of the

practice” in MC simulations, enough history should be calculated to

28
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F I G . 1 . A cross‐section view of the
simulated Mevion S250 treatment nuzzle
for the deep group (distance from the
proton source to the isocenter was
205 cm).
ensure that MC results have at least 1σ (k = 1, 67% conﬁdence index)

Spread (ES), Spot Size (SS), Beam Angle (BA), and Offset from central

<1% statistical uncertainty at depths of interest in the water and air.

Axis (OA). FS thickness was the only treatment nozzle parameter used

19

The mesh tally detector was used due to its functionality for pro-

for the sensitivity investigations. In this step, all 24 options of Mevion

ton dose calculations.19 The photons, electrons, protons, and posi-

S250 were simulated in different stages to obtain the uncertainty of the

trons were suppressed for simulations with a cutoff energy of

derived results on the depth of the pristine peak, shape, and symmetry

990 eV, 57.3 keV, 5 keV, and 56.6 keV respectively.
For comparison purposes, the results were then compared with
the derived values from TOPAS (version 2.0) simulations.20

of the resulting dose proﬁles, as well as LETt and LETd distributions. For
the depth of pristine peak, the dose distribution was evaluated using
the distal 90% (D90%). Because, each SOBP was created by superimposing single Bragg peaks, the sensitivity study of the pristine peaks
also reﬂects uncertainties associated with SOBPs.10,13,15 The ﬂatness

2.A.2 | LET
After tuning the treatment nozzle for all the 24 options, both
track‐averaged LETt and dose‐averaged LETd, were calculated

and symmetry of the proﬁles were analyzed using the method proposed
by Prusator et al.20 as follow:
Flatness ¼ ðDmin  Dmax Þ=ðDmin þ Dmax Þ  100

(1)

according to the method by Guan et al.7 It should be noted that,
LETt calculated as the arithmetic mean value of the ﬂuence spectrum, matches the deﬁnition by the ICRU, and LETd is a quantity
that accounts for both physical dose and LET, to predict biological

where, Dmin and Dmax are, respectively, the minimum and maximum
doses within the central axis of the beam to the 80% dose levels.


Symmetry ¼ LDintegral  RDintegral = LDintegral þ RDintegral  100

effects.7,19
To calculate both LETt and LETd, the detector cells were modeled as spheres on the central axis of the beam in water phantom.
The MCNPX LET special tally was employed to record ﬂux over the
cells as a function of stopping power instead of energy.19 Using this
tally, the recorded values in the energy bins are interpreted as stopping power values (units of MeV/cm).

(2)

where, LDintegral and RDintegral are the integral doses of the left and
right side of the radiation ﬁeld respectively.
The stages included in the sensitivity study were the AE (±9%),
the ES (FWHM) [up to +20%], SS (up to +7 mm), BA (0°–2°), OA,
and SO (up to +15 mm), and increasing FS thickness (10%). The variations in each stage revealed the potential uncertainties in these
parameters. These uncertainty values were chosen based on clinical
operation, representing the likely extent of adjustments required to

3 | SENSITIVITY ANALYSIS

bring a system to within acceptable tolerances.
Since for each group (large, deep, and small), treatment nozzle

The sensitivity of the model to changes in machine proton source

conﬁgurations are very similar in design, in this study we will only

parameters was analyzed by varying the Average Energy (AE), Energy

refer to the group, instead of the option, for the sensitivity analysis.

|
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4 | RESULTS
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The Mevion S250 was found to have a LETt between 0.46 and
8.76 keV.μm–1 and a corresponding LETd between 0.84 and

With the number of simulated histories used, the uncertainty asso-

15.91 keV.μm–1. The distributions of LETt and LETd as a function of

ciated with statistical (quantum) uncertainty in the MC‐calculated

depth for options 3, 14, and 23 are shown in Fig. 3. After the distributions

results in air was less than 0.50% at all distances in the transverse

of LETt and LETd for each option were established for a single Bragg

plane. For the large group, the statistical uncertainty for calculations

peak, it was easy to superimpose several LETt and LETd for more com-

in water was less than 0.61% for the depths of 25.0 cm (D90% of

plex situations, according to the deﬁned BCM for each Bragg peak.21

the deepest Bragg Peak). Whereas, for the deep and small groups,
it was 0.94% and 0.69% for D90% of 31.9 and 20.0 cm, respectively.
This statistical uncertainty made it feasible to investigate notice-

4.B | Sensitivity analysis
4.B.1 | Average energy

able effects on the physical dose distribution due to slight changes

In this study, using the 250 MeV nominal beam energy of the sys-

of the sensitivity study parameters. In other words, high precision

tem, the predicted D90% was within 3 mm for the small group, com-

was obtained in the results of the simulations, which was due to

pared to the experimental measurements. For the large and deep

simulating large numbers of histories.

groups, even less discrepancy (<2 mm) was seen.
Fig. 4, illustrates the absolute difference between the measured
and MC derived depth of D90% as a function of changes in the AE

4.A | Physical dose and LET

for each group (large, deep, and small). As expected, there were dif-

For the pristine peak, the MCNPX MC model of the Mevion S250

ferences among these groups since each group uses a unique treat-

matched measurements data for all the 24 options to within 2% of

ment nozzle conﬁguration. Slight changes in the AE (3%) signiﬁcantly

the dose points compared and 1 mm for the distances to agreement

inﬂuenced the D90% (up to 26.6 mm) for small group. Whereas, for

(within 2% or 1 mm criterion). Table 1, shows comparison of derived

the large and deep groups, up to 23.4 and 22.1 mm, respectively,

percent depth dose data with MCNPX, for the large, deep, and small

changes of the D90% was observed. Moreover, the deep group was

options, with measurements and TOPAS simulations for this system.

less sensitive to 9% AE uncertainty (up to 57.3 mm), compared to the

Comparing the MCNPX and TOPAS results, there were differences

large (58.8 mm) and small groups (61.1 mm).

of up to 1.4% in the derived DD0.5

cm,

the largest discrepancies

occurring in the deep options.

Altering the proton beam energy to 109% showed a strong
effect on the small group proﬁle ﬂatness (up to 8.6%), whereas

Fig. 2 illustrates a comparison between the derived lateral beam

results on the symmetry of the proﬁles were not signiﬁcant (less

proﬁles in this study with the measured values, where only the

than 2.2%) and remained within the statistical uncertainty of the MC

data for options 6, 13, and 24 are presented for the sake of brev-

calculations. Figure 5, demonstrates the variations of the ﬂatness

ity. The largest dose discrepancy between MC calculations and

and symmetry of lateral proﬁles for the small group due to 9%

measurements was 2% and in the penumbra region, whereas,

increase in the AE.

between the 80% and 20% dose levels the distance‐to‐agreement
was less than 1.0 mm. For the TOPAS simulations, the absolute differences in the penumbras between simulated and measured pro-

4.B.2 | Energy spread (FWHM)

ﬁles at each depth for each conﬁguration all agreed to well within

Figure 6, shows the absolute difference between the baseline and sen-

0.6 mm.

sitivity derived width of the pristine peaks and peak‐to‐plateau ratios

Flatness and symmetry of the proﬁles for the large group were

(peak‐to‐plateauSensitivity/peak‐to‐plateauBaseline) of the studied groups

less than 1.44% and 0.40%, respectively, whereas, for the deep

(large, deep, and small). Due to 20% increase in the ES, the maximum

group they were 1.18% and 0.30%, respectively. Small group

increase in the width of the pristine peaks were 4.1 and 2.9 mm for the

showed the lowest ﬂatness and symmetry (2.18% and 0.60%,

large and deep groups respectively, whereas, the maximum decrease in

respectively).

the peak‐to‐plateau ratio were 4.5% and 1.6%, respectively. For the

For all the SOBPs, the distal 90% and 20% depths were
matched with measurements within 1.0 and 1.7 mm differences,

small group, the maximum differences for the width of the pristine
peaks and peak‐to‐plateau ratios were 4.4 mm and 9.5%, respectively.

respectively. For width of the created SOBPs, the largest discrepancy was less than 2.0 mm compared to the experimental measurements.

4.B.3 | Spot size

Based on the treatment nozzle benchmarking results, for all the

It was revealed that changes of the SS resulted in no signiﬁcant

24 options, the primary proton source energy was ﬁnally set to be

effect on the pristine peaks D90% (<1 mm). Figure 7 gives the

252 MeV with an initial Gaussian distribution proﬁle in energy (σE =

changes of distal width and peak‐to‐plateau ratio of the pristine

0.40 MeV) and in space (σx = σy = 2.7 mm). The nominal energy

peaks due to uncertainty associated with SS in large, deep, and small

provided by the vendor was 250 MeV and the energy spread was

groups. It was observed that, considering up to 3 mm uncertainty of

0.4% (RMS).

the SS, there was no signiﬁcant effect on the distal width (<1 mm)

30
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T A B L E 1 Comparison of derived percent depth dose data with MCNPX, for the large, deep, and small options, with measurements and
TOPAS simulations.20 Data are presented for dose at depth of 0.5 cm (DD0.5 cm) and 3.0 cm (DD3.0 cm) and the beam range, deﬁned as the
depth of 90% dose (D90%) on distal fall‐off.
ΔDD0.5

Option
Large group

Deep group

Small group

cm

(%)

ΔDD0.5 cm (%)
[TOPAS]

ΔDD3.0

cm

(%)

Measured
D90% (cm)

Δa in D90% (cm)

Δ in D90% (cm)
[TOPAS]

1

1.4

0.8

1.0

24.95

0.02

0.04

2

0.7

0.8

0.6

22.63

0.03

0.05

3

1.1

0.4

1.1

20.96

–0.06

‐0.05

4

1.5

0.5

1.6

18.82

0.04

0.07

5

0.7

1.1

0.5

16.84

0.05

0.06

6

1.7

1.5

1.4

14.87

–0.05

0.04

7

0.8

1.0

1.7

13.16

0.04

0.05

8

0.6

0.6

0.6

11.45

0.04

‐0.09

9

1.6

1.2

1.4

10.07

0.04

0.05

10

1.2

0.5

1.2

8.66

0.03

0.09

11

0.2

1.5

0.4

7.35

0.04

0.08

12

1.7

1.3

1.6

6.13

0.05

0.09

13

1.9

1.2

1.5

31.95

0.03

0.04

14

0.4

0.6

0.5

29.48

0.04

0.00

15

1.1

1.6

0.8

26.94

0.03

0.02

16

0.4

1.8

0.4

24.49

0.04

0.03

17

0.9

1.1

1.2

22.12

0.04

0.04

18

1.4

1.5

1.3

20.06

0.03

0.05

19

0.4

1.9

0.6

17.81

–0.06

0.07

20

1.3

0.3

1.3

15.43

0.03

0.07

21

1.6

1.5

0.8

13.36

0.02

0.02

22

0.8

1.7

1.3

11.18

–0.03

0.04

23

1.1

0.6

1.0

9.10

–0.05

0.00

24

0.3

1.2

0.6

7.01

–0.05

0.00

1.03 (1.9)

1.09 (1.9)

1.01 (1.7)

Avg. (Max)
a

Discrepancy (D90%

Measurement

– D90%

0.039(0.06)

0.048 (0.09)

MCNPX Simulation).

and peak‐to‐plateau ratio (<1%) owing to the beam spot size change.

On the other hand, a 0.6° deviation from normal was found to

In our study, the distal width of a Brag peak was deﬁned as the dif-

change the ﬂatness by 2.7% for small group and 1.8% for deep

ference between the 10% and 90% dose on the distal fall‐off.

group (Table 2). The maximum effect was seen for the small group

Noticeable effect on the distal width (about 2 mm) was seen for SS

(up to 7.6%) for a 2.0° proton beam deﬂection. The symmetry was

of 10 mm, especially for the small group (Fig. 7).

less affected by the BA, as to see a 2.0% decrease in the ﬂatness of

Therefore, the beam SS have little inﬂuence on pristine peaks

the proﬁles; the proton beam should be deﬂected by a minimum of

and the effects might be too subtle to produce signiﬁcant changes

0.6° for the small option. For the large and deep options, more beam

to the distal width of the dose distribution.

deﬂection was needed (>0.9°) to reproduce a same effect. The 2%

Varying the proton beam SS resulted in negligible effect (<1%)

criterion for the ﬂatness and symmetry was selected to present the

on the ﬂatness and symmetry of the small group. The changes for

likely level of adjustments needed to bring a proton system to within

the large and deep groups were also remained approximately within

acceptable clinical speciﬁcations. Moreover, it may be of an interest

the statistical uncertainty of the calculations.

for tuning a MC simulation of clinical proton systems.

4.B.4 | Beam angle

4.B.5 | Offset from central axis

Figure 8 shows that the 2° incident angle of the proton beam had a

For a given lateral offset of 3 mm, the beam ﬂatness and symmetry

signiﬁcant effect on the peak‐to‐plateau ratio (up to 4.5% decrease)

were signiﬁcantly affected, more strongly, for small (3.7% and 3.3%)

of the Bragg peaks, whereas, the effects on the depth of D90%

and large (3.5% and 2.8%) groups, compared to the deep group

were small (<1 mm).

(2.4% and 2.4%). As expected, increasing the OA for up to 15 mm

|
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sensitive on the OA and SO small changes compared to the other
treatment nozzle conﬁgurations.

4.B.6 | First Scatter thickness
In this work, it was hypnotized that changes in the thickness of the
lead FS have a much more prominent effect on the depth of D90%.
The maximum thickness of the FS is 8.370 mm (large group‐ option
12) to 1.322 mm (deep group‐ option 17) depending on the treatment nozzle conﬁguration. Therefore, options 1 and 13 with corresponding FS thickness of 6.167 mm and 1.322 mm, respectively,
were selected for the sensitivity analysis.
For the small group, there is no FS in the treatment nozzle conﬁguration; therefore, we were unable to investigate the sensitivity of
the derived dose distribution due to uncertainty in FS thickness. FigF I G . 2 . Comparison between the MCNPX derived (red) and
measured (black) lateral beam proﬁles for options 6 (large group), 13
(deep group), and 24 (small group). The lateral beam dose proﬁles for
options 13 and 24 are multiplied by 0.8 and 0.6, respectively, to
show all three comparisons in one graph.

ure 11 gives the changes of the depth of D90% as a function of FS
thickness for large and deep options. Changes in FS thickness affect
the range, especially for the large group (up to 5 mm).
Increasing the FS thickness within the tolerances in this study
(up to 10%), had a comparatively minor effect on the proﬁle ﬂatness
and symmetry (less than 2%).

signiﬁcantly decreased ﬂatness and symmetry of the proﬁles, especially for small option (31.0% and 11.4%). Figure 9 gives variations
of the ﬂatness and symmetry of the large group proﬁles due to

4.B.7 | LET

uncertainty in the OA. Similar results were observed for the SO. In

For the small group due to 9% increase in the AE, in the peak region

other words, considering the statistical uncertainty of the MC

the LETd decreased by up to 2.03 keV/μm−1 representing 12.8% of

results, OA was indistinguishable from SO. Figure 10 shows changes

its maximum value, whereas LETt was decreased by up to 1.59 keV/

in the ﬂatness and symmetry of the proﬁles due to uncertainty asso-

μm−1 (14.6% of its maximum value). In the plateau region, LETd and

ciated with SO from the central axis.

LETt were less affected (up to 4.9% and 2.7%, respectively). In other

Moreover, 3–15 mm OA resulted in change of D90% (up to

words, LETt was less sensitive than the LETd by up to 2.2%. For this

3 mm). According to our results, small groups was found to be more

group, the plateau maximum values of the LETd and LETt were

F I G . 3 . Distributions of LETt (green) and
LETd (blue) as a function of depth for each
main Bragg peak of the options 3 (large
group), 14 (deep group), and 23 (small
group).
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60

(a)

Large Option
Deep Option
Small Option

40

ΔR (mm)

20
0
-20
-40
-60
220

230

240

250

260

270

280

Average Energy (MeV)
F I G . 4 . The absolute difference (ΔR) between the baseline and
MC derived depth of D90% as a function of changes in the AE for
large, deep, and small groups.

(b)

1.00

Peak-to-plateau ratio

0.98
140

Relative dose (%)

120
100
80
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derived width of the pristine peaks (a) and peak‐to‐plateau ratios (b)
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small). Peak‐to‐plateau ratio was derived based on the ratio of the
peak‐to‐plateaus of sensitivity results to the baseline values (peak‐to‐
plateauSensitivity/peak‐to‐plateauBaseline).

0.89 keV/μm−1 and 0.54 keV/μm−1 respectively. For the small group,

6% respectively). For the deep group, decrease in the LETt and LETd

slight changes in the AE (<3%) did not signiﬁcantly inﬂuence the

was remained within less than 1% of their maximum values. Both

LETs (less than 2%). Our results showed that, deep group was less

LETt and LETd in the plateau region were even less sensitive (<1%) to

sensitive in the both peak (<4.7%) and plateau (<2%) regions com-

changes in the ES within the uncertainties studied in this work. Fig-

pared to the small group. For deep group, the maximum values of

ure 13, shows the variations in the LETd (dash line) and LETt (solid

the LETt and LETd were 6.97 keV/μm−1 and 13.42 keV/μm−1 respec-

line) distributions due to increase in the ES for the large option.

tively. The maximum values of the LETd and LETt in the plateau

Due to 7 mm increase in the SS, the maximum decrease in the

were 0.84 keV/μm−1 and 0.46 keV/μm−1 respectively. Figure 12,

LETd and LETt for the large group was up to 0.56 keV/μm−1and

illustrates changes of the LETt and LETd distributions due to 3% and

0.34 keV/μm−1, respectively, representing 4.1% and 4.8% of their

5% increase in the AE for the large group.

maximum value. For this group, up to 5 mm increase in the SS,

As ES becomes larger (up to 20%), for all the groups, the absolute

resulted in slight changes of the LETs (<2%). For the deep group,

maximum of LETd and LETt become lower (up to 1.67 keV/μm−1 and

changes were within 1% of their maximum values. For small and

1.23 keV/μm−1, respectively), and less steep at the end of the range

large groups, both LETd and LETt were less steep at the end of the

(Fig. 13). Increasing the ES resulted in decrease in LETt and LETd for

range (Fig. 14). Figure 14, shows variations of the LETt and LETd dis-

the peak regions, especially for the small group (up to 9.2% and 9.

tributions due to increase in the SS for the small group. For all the
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5 | DISCUSSION
There is no literature available on the sensitivity analysis of physical

Normalized dose (%)

cant (<1%).
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dose and LET distributions of Mevion S250 as a passive double scat-
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tering compact proton therapy unit.
The MCNPX benchmarked physical dose with the measured data
showed up to 2% or 1 mm discrepancy (Table 1; Fig. 2), mainly due
15

to the physical properties of various materials

in the treatment

nozzle as well as uncertainty associated with the cross section
library,22,23 which were not evaluated in this work. However, it has
been stated that the default conﬁgurations, i.e. cross section library,
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F I G . 9 . Variations of the ﬂatness and symmetry of the large group
proﬁles due to uncertainty in the OA.
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sources of uncertainty in simulation due to the difﬁculty in measuring it. Similar to our ﬁndings, it has been reported that, the ﬁnite

12

width and peak‐to‐plateau ratio of the Bragg peak is very sensitive

10

to the ES of the proton beam.13,15 It should be noted that, for a pro-

8

ton system, the relationship between AE and ES is not known accurately. Our results were in a good agreement with Paganetti et al.13

6

who simulated the Francis H Burr proton beam treatment nozzle, at

4

the Northeast Proton Therapy Center at Massachusetts General

2

Hospital, to aid in the commissioning process and support clinical

0

operation. They found that, increasing the energy spread results in

0
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14

16

Second Scatter Offset (mm)
F I G . 1 0 . Changes in the ﬂatness (a) and symmetry (b) of the
proﬁles due to uncertainty associated with second scatter offset
from the central axis.

the broadening of the Bragg peak and consequently decrease in the
peak‐to‐plateau ratio. Bednarz et al. stated that change in beam
energy spread does not have a noticeable effect on the uniformity
of the SOBP.15 We found that, for the Mevion S250, variations of
the proton ES had no signiﬁcant effect on the ﬂatness and symmetry
of the beam proﬁle for the large and deep groups. For the small
group, up to 2.6% decrease in the beam ﬂatness was observed due

of the MCNPX MC code lead to results that are within to the clinically used quality assurance criteria.24

to 20% change in the ES.
On the other hand, it has been reported that, the beam SS may

Results of the MCNPX simulation were in reasonably good

inﬂuence the peak‐to‐plateau ratio of pristine Bragg peaks, and

agreement with the TOPAS simulations (<2% of the dose points

accordingly the SOBPs uniformity.15 Some publications have shown

compared and <1 mm for the distances) (Table 1). Small differences

that the beam spot size adjustments can be based on the steepness

between the MCNPX and TOPAS, especially for the lateral beam

of the distal fall‐off and the peak/plateau ratio, both being quite sen-

proﬁles, may be due to the shape of the aperture cut‐out, which was

sitive to this parameter.10,13 For the Mevion S250 proton system,

relevant for penumbra region and was more difﬁcult to model accu-

we observed up to 2 mm increase in the distal width of the pristine

rately in MCNPX. Zhao et al. observed noticeable differences along

peaks due 7 mm increase in the SS, especially for the small group

the ﬁeld edges, both inside and outside of the ﬁelds, at shallow

(Fig. 7).

depths. They stated that, the differences were signiﬁcantly
decreased with increasing depth in water.2

We found that BA, OA, and SO signiﬁcantly decreased the ﬂatness and symmetry of the proﬁles (Figs. 8–10). Up to 2.0° tilt of pro-

MCNPX model sensitivity analysis for all the options revealed

ton beam resulted in nonsigniﬁcant effect on the D90% (<1 mm),

that, the AE and ES had the greatest effect on the D90% and peak‐

while variations in the peak‐to‐plateau ratio were signiﬁcant (Fig. 8).

to‐plateau ratio (Figs. 4–6) respectively. Although, the AE of a proton

For the Mevion S250, the slope of the lexan and lead layers of sec-

beam is not as of clinical interest as the range, since the range can

ond scatter are greater near its central axis.2 Therefore, slight

15

it should be known as starting points

changes in the beam SO (3 mm) produced signiﬁcant uncertainty on

for the MC simulations. The ES can provide one of the largest

the shape of the proﬁles, for all the studied options. The minimum

be measured very accurately,
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and LETt (solid line) distributions due to
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distributions due to increase in the SS for the small group.

OA required to induce a 2% change in symmetry was roughly 25%

another source of uncertainty that can be included in a reference

greater for the large option than for the small conﬁguration (Table 2).

library guiding clinical medical physicists and engineers to trou-

Moreover, ﬂatness of the proﬁle was more sensitive to SO and OA

bleshoot and repair the machine, and also to tune the beam parame-

changes near the central axis than in the periphery of the ﬁeld, espe-

ters to within clinically acceptable levels. Therefore, the proton beam

cially for small options. For deep group, the 5 mm OA from the cen-

line and second scatter must be taken into account as a system to

tral axis can signiﬁcantly change the symmetry of the proﬁle (up to

evaluate changes in the shape of the proﬁles. While for a proton

7.5%), while for small group lesser changes of OA (4 mm) was

system already in clinical use, determining reasonable tolerances in

needed to produce a same effect (Figs. 8 and 9). This results in

all the moving parts in the beamline can be difﬁcult, some

36
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measurements, i.e. beam proﬁle due to second scatter offset, during

region due to its characteristics of continuous increase along beam

acceptance testing of a new system may be helpful for later Monte

path and lower sensitivity to beam uncertainties. It means that a

Carlo commissioning work.

spatially variant switch between the use of LETt and LETd to quan-

In addition to the uncertainties studied in this work, physics con-

tify the LET is recommended for biological studies.

stants of various materials used in the construction of the treatment

Recently, the idea of adaptive treatment planning by LET painting

nozzle may produce another source of uncertainty.16 Previous stud-

has started its development in the framework of TPS.4 Based on this

ies have shown a signiﬁcant sensitivity in MC calculated dose distri-

idea, for a passively scattered proton treatment plan, optimization

bution on the variations in properties of materials used in passive

algorithm can attempt to minimize the volume of normal tissues

scattering proton therapy treatment nozzles.15 Based on the sensitiv-

exposed to high LETd, resulting in reducing radiation‐induced toxicity.

ity study performed on IBA (Louvain‐la‐Neuve, Belgium), the authors
have reported that slight changes in density of the materials of ﬁeld
shaping parts clearly inﬂuenced the range and uniformity of dose

6 | CONCLUSIONS

15

distribution.

These results can be used to improve quality assurance proce-

This study presents a detailed sensitivity analysis of most important

dure or speed up commissioning process, especially for the commis-

but often poorly speciﬁed beam parameters required for simulating a

sioning of MC models of clinical passively scattered proton beams.

gantry‐mounted passively scattered proton system. Our results

Commissioning a MC model of a passively scattered proton can be a

revealed the importance of these parameters specially those resulted

more rigorous and difﬁcult process than it is for more standard treat-

in large effects on the physical dose distribution and/or LETs, i.e.,

ment planning softwares. Correlating the many adjustable simulation

average proton beam energy, initial energy spread, spot size, and off-

parameters of the nuzzle with measurable dose distributions can

set from the central axis. The ﬁndings can be used as a useful tool

notably facilitate the commissioning process. Moreover, to speed up

when quality assurance of this system. Moreover, the sensitivity

the quality assurance of this system our results are an effective

analysis can also be used to aid machine design for determining rea-

means of relating nuzzle parameters to clinical measurements.

sonable tolerances in all the moving parts in the beamline. The simu-

The RBE of proton therapy is a function of dose, tissue endpoint,
4

lation results from the sensitivity analysis can be utilized to

and energy deposition characteristics. In this regard, the LET can be

construct a reference library to guide troubleshooting and repairing

used to parameterize the latter for proton beams, by taking into

for the machine as well.

account range uncertainties, for a given dose and biological endpoint.3,6 It is known that, the LET distribution in a proton beam
depends on the range,25 therefore, uncertainty associated with range
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however, both LETs are highly sensitive to variations in energy near
the Bragg peak when proton energy become low.3,7 It has been stated that, for the passive‐scattering unmodulated monoenergetic proton beams of 250 MeV at the Proton Therapy Center at Houston
(PTCH), LETt is between 0.45 and 5.95 keV.μm–1.26 For proton
beamlet of 201 MeV, the maximum LETt and LETd were reported to
be 10.4 and 15.3 keV.μm–1, respectively, signiﬁcantly higher, as
expected, than the values calculated in our work.7
In our study, considering the sensitivity study of the LET, it was
found that in the peak region, depending on the option, both LETt
and LETd were sensitive to changes of AE, ES, and SS (Fig. 12–14).
However, compared to the LETd which showed higher sensitivity in
the plateau region, LETt showed higher sensitivity in the peak (up to
1.8%).
According to the previous reports for biological dose calculations,
LETd is more appropriate than the LETt at therapeutically relevant
dose levels.3 On the other hand, the proton biology experiments
have shown the role of LET in the plateau region for determining
cell kill is small.7 Therefore, in line with previous recommendation of
Guan et al.3, we recommend the use of LETt in the dose plateau

REFERENCES
1. Newhauser WD, Zhang R. The physics of proton therapy. Phys Med
Biol. 2015;60:R155–209.
2. Zhao T, Sun B, Grantham K, et al. Commissioning and initial experience with the ﬁrst clinical gantry‐mounted proton therapy system. J
Appl Clin Med Phys. 2016;17:24–40.
3. Grassberger C, Troﬁmov A, Lomax A, Paganetti H. Variations in linear energy transfer within clinical proton therapy ﬁelds and the
potential for biological treatment planning. Int J Radiat Oncol Biol
Phys. 2011;80:1559–1566.
4. Paganetti H, Blakely E, Carabe‐Fernandez A, et al. Report of the
AAPM TG‐256 on the relative biological effectiveness of proton
beams in radiation therapy. Med Phys. 2019;46:e53–e78.
5. Luhr A, von Neubeck C, Pawelke J, et al. "Radiobiology of Proton
Therapy": results of an international expert workshop. Radiother
Oncol. 2018;128:56–67.
6. Carabe A, Moteabbed M, Depauw N, Schuemann J, Paganetti H.
Range uncertainty in proton therapy due to variable biological effectiveness. Phys Med Biol. 2012;57:1159–1172.
7. Guan F, Peeler C, Bronk L, et al. Analysis of the track‐ and dose‐averaged LET and LET spectra in proton therapy using the geant4
Monte Carlo code. Med Phys. 2015;42:6234–6247.

BARADARAN‐GHAHFAROKHI ET AL.

8. Sechopoulos I, Rogers DWO, Bazalova‐Carter M, et al. RECORDS:
improved reporting of montE CarlO RaDiation transport studies:
report of the AAPM research committee task group 268. Med Phys.
2018;45:e1–e5.
9. Paganetti H. Range uncertainties in proton therapy and the role of
Monte Carlo simulations. Phys Med Biol. 2012;57:R99–117.
10. Polf JC, Harvey MC, Titt U, Newhauser WD, Smith AR. Initial beam
size study for passive scatter proton therapy. I. Monte Carlo veriﬁcation. Med Phys. 2007;34:4213–4218.
11. Schreiber EC, Sawkey DL, Faddegon BA. Sensitivity analysis of an
asymmetric Monte Carlo beam model of a Siemens Primus accelerator. J Appl Clin Med Phys. 2012;13:3402.
12. Carabe A, Espana S, Grassberger C, Paganetti H. Clinical consequences of relative biological effectiveness variations in proton
radiotherapy of the prostate, brain and liver. Phys Med Biol.
2013;58:2103–2117.
13. Paganetti H, Jiang H, Lee SY, Kooy HM. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a
proton radiation therapy facility. Med Phys. 2004;31:2107–2118.
14. Yepes P, Adair A, Grosshans D, et al. Comparison of Monte Carlo
and analytical dose computations for intensity modulated proton
therapy. Phys Med Biol. 2018;63:045003.
15. Bednarz B, Lu HM, Engelsman M, Paganetti H. Uncertainties and
correction methods when modeling passive scattering proton therapy treatment heads with Monte Carlo. Phys Med Biol.
2011;56:2837–2854.
16. Sheikh‐Bagheri D, Rogers DW. Sensitivity of megavoltage photon
beam Monte Carlo simulations to electron beam and other parameters. Med Phys. 2002;29:379–390.
17. Kerstiens J, Johnstone GP, Johnstone PAS. Proton facility economics: single‐room centers. J Am Coll Radiol. 2018;15:1704–1708.

|

37

18. Das IJ, Cheng CW, Watts RJ, et al. Accelerator beam data commissioning equipment and procedures: report of the TG‐106 of the
Therapy Physics Committee of the AAPM. Med Phys.
2008;35:4186–4215.
19. Waters L, Hendricks J, McKinney G. MCNPX. Los Alamos, NM: Los
Alamos National Laboratory. 2005.
20. Prusator M, Ahmad S, Chen Y. TOPAS simulation of the mevion
S250 compact proton therapy unit. J Appl Clin Med Phys.
2017;18:88–95.
21. Wilkens JJ, Oelfke U. Analytical linear energy transfer calculations
for proton therapy. Med Phys. 2003;30:806–815.
22. Mosleh‐Shirazi MA, Hadad K, Faghihi R, Baradaran‐Ghahfarokhi M,
Naghshnezhad Z, Meigooni AS. EchoSeed Model 6733 Iodine‐125
brachytherapy source: improved dosimetric characterization using
the MCNP5 Monte Carlo code. Med Phys. 2012;39:4653–4659.
23. Jarlskog CZ, Paganetti H. Physics settings for using the Geant4
toolkit in proton therapy. IEEE Trans Nucl Sci. 2008;55:1018–1025.
24. Titt U, Sahoo N, Ding X, et al. Assessment of the accuracy of an
MCNPX‐based Monte Carlo simulation model for predicting three‐dimensional absorbed dose distributions. Phys Med Biol.
2008;53:4455–4470.
25. Paganetti H. Relative biological effectiveness (RBE) values for proton
beam therapy. Variations as a function of biological endpoint, dose,
and linear energy transfer. Phys Med Biol. 2014;59:R419–472.
26. Wang LL, Perles LA, Archambault L, Sahoo N, Mirkovic D, Beddar S.
Determination of the quenching correction factors for plastic scintillation detectors in therapeutic high‐energy proton beams. Phys Med
Biol. 2012;57:7767–7781.

